ValorQ4, 24Q1, 25Q2, 25Q3, 25Q4, 25TTMGastos comerciales, generales y administrativos746.8 M758.8 M814.8 M811.4 M872.2 M3.26 BInvestigación y desarrollo108.5 M110.6 M113.3 M115.9 M118.7 M458.5 MBeneficio operativo389 M292.3 M300 M351.3 M154.5 M1.1 BTotal de ingresos no operativos-47 M4.3 M10.7 M-7.8 M4.1 M11.3 MGastos por intereses, netos de intereses capitalizados——————Ingresos no operativos, una vez deducidos los gastos por intereses-8.9 M1.4 M6.8 M-11.1 M-11.3 M-14.2 MIngresos/gastos extraordinarios-38.1 M2.9 M3.9 M3.3 M15.4 M25.5 MBeneficio antes de impuestos289 M229 M224.6 M279.2 M98 M830.8 MParticipación en los beneficios——————Impuestos48.9 M46.5 M71.2 M48 M-40 M125.7 MParticipación minoritaria——————Otros ingresos/gastos después de impuestos——————Beneficio neto antes de actividades interrumpidas239.5 M182 M152.8 M230.9 M139.4 M705.1 MOperaciones suspendidas0—————Beneficio neto239.5 M182 M152.8 M230.9 M139.4 M705.1 MAjuste por dilución——————Dividendos de las acciones preferentes——————Beneficio neto diluido atribuible a los accionistas239.5 M182 M152.8 M230.9 M139.4 M705.1 MBeneficio básico por acción1.20.920.771.170.73.56Beneficio por acción diluido1.180.910.771.160.713.55Número medio de acciones ordinarias203.1 M198.9 M197.9 M198.1 M198 M792.9 MAcciones diluidas203.9 M199.7 M198.3 M198.8 M198.7 M795.5 MEBITDA590.8 M480.5 M492.5 M559.5 M366.6 M1.9 BEBIT327.2 M226.1 M220.7 M275.9 M82.6 M805.3 MCosto de los ingresos586.7 M549.8 M592.2 M559.3 M792.4 M2.49 BOtros costes de producción——————Amortización y depreciación (flujo de caja)263.6 M254.4 M271.8 M283.6 M284 M1.09 B
Zimmer Biomet Holdings Inc
Zimmer Biomet Holdings, Inc. is a publicly traded American medical device company. It was founded in 1927 to produce aluminum splints. The firm is headquartered in Warsaw, Indiana, where it is part of the medical devices business cluster.
In 2001, Zimmer was spun off from Bristol Myers Squibb and began trading on the New York Stock Exchange, on August 7, under the ticker symbol “ZMH”. In November 2011, the company acquired ExtraOrtho, Inc. In January 2012, the company acquired Reno, Nevada-based Synvasive Technology, Inc. On June 29, 2015, the company changed the ticker symbol to "ZBH" to reflect its acquisition of Biomet.
On January 12, 2017, Zimmer Biomet announced a resolution with the DOJ and the SEC in which it agreed to pay a fine of approximately $30.5 million, an amount which would not affect its 2017 outlook.